Vimarsana
Biggest News Aggregation in the World

Page 5 - C Difficile News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from C Difficile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In C Difficile Today - Breaking & Trending Today

Study Details Risk of C difficile With Clindamycin, Other Antibiotics - Vimarsana News

Study Details Risk of C difficile With Clindamycin, Other Antibiotics

Study results suggest the greatest risk for Clostridioides difficile infection was observed with use of clindamycin while the lowest risk was observed with doxycycline and minocycline.

Source: ajmc.com
Evidence Insufficient to Show That Probiotics Prevent CDI - Vimarsana News

Evidence Insufficient to Show That Probiotics Prevent CDI

Although 3 of 7 studies analyzed demonstrated that using probiotics could help prevent the development of Clostridioides difficile infection (CDI) in older patients, the researchers did not find a consensus among them all.

Source: ajmc.com
Hospitals Finds Low Rates of Asymptomatic Toxigenic C difficile Carriage - Vimarsana News

Hospitals Finds Low Rates of Asymptomatic Toxigenic C difficile Carriage

The study was designed to help scientists better understand how to prevent in-hospital transmission of Clostridioides difficile.

Source: ajmc.com
Two-Step Testing Helps Predict and Treat Recurrent C difficile Infection - Vimarsana News

Two-Step Testing Helps Predict and Treat Recurrent C difficile Infection

This study explores the effectiveness of toxin testing in predicting Clostridioides difficile infection (CDI) outcomes, revealing that patients with negative toxin results were less likely to experience CDI recurrence within 30 days.

Source: ajmc.com
Patient Age, Antibiotics, and FMT Donor Influence Recurrent C. Difficile Resolution - Vimarsana News

Patient Age, Antibiotics, and FMT Donor Influence Recurrent C. Difficile Resolution

New cohort analysis data provide more context into what factors influence the benefit of FMT in patients with recurrent CDI.